Dextech Medical AB (NGM:DEX)

Dextech Medical AB Income Statement

Financials in millions SEK. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	4.98	5.39	8.71	3.12	0.63	0.6
Revenue Growth (YoY)	-31.41%	-38.18%	179.60%	390.65%	6.48%	-73.66%
Cost of Revenue	1.9	-	-	-	-	1.98
Gross Profit	3.08	5.39	8.71	3.12	0.63	-1.38
Selling, General & Admin	4.48	7.25	10.59	5.36	2.58	0.72
Operating Expenses	8.57	10.93	13.65	8.39	6.71	6.33
Operating Income	-5.49	-5.55	-4.94	-5.27	-6.08	-7.71
Interest Expense	-	-	-	-	-0	-0
Interest & Investment Income	0.68	0.84	0.35	-	-	-
Pretax Income	-4.81	-4.71	-4.59	-5.27	-6.08	-7.71
Net Income	-4.81	-4.71	-4.59	-5.27	-6.08	-7.71
Net Income to Common	-4.81	-4.71	-4.59	-5.27	-6.08	-7.71
Shares Outstanding (Basic)	19	19	18	17	15	15
Shares Outstanding (Diluted)	19	19	18	17	15	15
Shares Change (YoY)	2.51%	2.51%	8.02%	14.72%	-0.11%	1.20%
EPS (Basic)	-0.26	-0.25	-0.25	-0.31	-0.41	-0.52
EPS (Diluted)	-0.26	-0.25	-0.25	-0.31	-0.41	-0.52
Gross Margin	61.84%	100.00%	100.00%	100.00%	100.00%	-231.26%
Operating Margin	-110.28%	-103.04%	-56.70%	-169.14%	-956.76%	-1293.51%
Profit Margin	-96.63%	-87.38%	-52.70%	-169.14%	-956.77%	-1293.53%
EBITDA	-4.94	-5.39	-4.77	-5.03	-5.81	-7.44
EBITDA Margin	-99.14%	-100.17%	-54.78%	-161.32%	-	-
D&A For EBITDA	0.55	0.15	0.17	0.24	0.27	0.28
EBIT	-5.49	-5.55	-4.94	-5.27	-6.08	-7.71
EBIT Margin	-110.28%	-103.04%	-56.70%	-169.14%	-	-
Revenue as Reported	5.39	5.39	8.71	3.12	0.63	0.6

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.